These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35461073)

  • 1. GALNT12 is associated with the malignancy of glioma and promotes glioblastoma multiforme in vitro by activating Akt signaling.
    Zheng Y; Liang M; Wang B; Kang L; Yuan Y; Mao Y; Wang S
    Biochem Biophys Res Commun; 2022 Jun; 610():99-106. PubMed ID: 35461073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
    Zhang A; Peng S; Sun S; Ye S; Zhao Y; Wu Q
    Cancer Med; 2024 Aug; 13(16):e70100. PubMed ID: 39149873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
    Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
    BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
    Sun Z; Xue H; Wei Y; Wang C; Yu R; Wang C; Wang S; Xu J; Qian M; Meng Q; Li G
    Clin Sci (Lond); 2019 May; 133(10):1167-1184. PubMed ID: 31076460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma.
    Li Q; Liu X; Mao J; Liu S; Hou B; Li K; Fang D
    Biochem Biophys Res Commun; 2023 Oct; 676():149-157. PubMed ID: 37517217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway.
    Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
    Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mTOR pathway.
    Liang L; Zhao Z; Jin Q; Zhang S; Zhao Z; Li X
    Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):80-86. PubMed ID: 37571896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.
    Li R; Li Y; Hu X; Lian H; Wang L; Fu H
    Biochem Cell Biol; 2016 Jun; 94(3):247-55. PubMed ID: 27105323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
    Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
    Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
    Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.
    Wang J; Li X; Wu H; Wang H; Yao L; Deng Z; Zhou Y
    J Cell Biochem; 2019 Oct; 120(10):17142-17150. PubMed ID: 31111534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ALDH1A1 in glioblastoma proliferation and invasion.
    Huang YK; Wang TM; Chen CY; Li CY; Wang SC; Irshad K; Pan Y; Chang KC
    Chem Biol Interact; 2024 Oct; 402():111202. PubMed ID: 39128802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival.
    Xiong Z; Wu S; Li FJ; Luo C; Jin QY; Connolly ID; Hayden Gephart M; You L
    Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292767
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
    Guo SK; Shen MF; Yao HW; Liu YS
    Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.